Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Teodóra Bánfalvi"'
Publikováno v:
Oncology. 64:374-379
Objective: Serum S-100B is a reliable tumor marker of malignant melanoma, but efficient use is restricted to patients with metastatic disease. Therefore, the aim of our study was to assess serum S-100B levels at different stages of malignant melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c0bdc5a9d8aca9e70d76e7fe0670fdc
https://doi.org/10.1159/000070296
https://doi.org/10.1159/000070296
Autor:
Szabolcs Ottó, Mária Gergye, Mariann Boldizsár, Tibor Kremmer, Teodóra Bánfalvi, Katalin Gilde
Publikováno v:
Pathology & Oncology Research. 8:183-187
5-S-cysteinyldopa is a precursor of pheomelanin. S-100B protein is a low molecular weight, acidic, calcium binding, cytoplasmatic protein. LDH was defined as the most important serum parameter in disseminated melanoma. The aim of the present study wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af526fe694b64dffaf11ec76b2f8b8d5
https://doi.org/10.1007/bf03032392
https://doi.org/10.1007/bf03032392
Autor:
Katalin Gilde, Gabriella Liszkay, M. Boldizsár, T. Kremmer, Teodóra Bánfalvi, B. Horváth, E. Beczássy, Zsuzsanna Fejos
Publikováno v:
European Journal of Clinical Investigation. 30:900-904
Background 5-S-cysteinyldopa (5-S-DC) is a precursor of melanin. Its serum and urinary level can reflect melanoma progression. In this study we examined the concentration changes of 5-S-CD in melanomas of different clinical stages and in patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e046ef45547b8407fd78a69e1f7610a
https://doi.org/10.1046/j.1365-2362.2000.00710.x
https://doi.org/10.1046/j.1365-2362.2000.00710.x
Autor:
Teodóra Bánfalvi, Zsuzsanna Fejos, Katalin Gilde, Gábor Péley, Miklós Kásler, István Sinkovics, Zsolt Orosz, Vanda Plótár, Gabriella Liszkay, Orsolya Csuka
Publikováno v:
Melanoma research. 15(6)
The prognostic significance of spontaneous regression of primary melanoma is a controversial issue. Studies on sentinel lymph node status and circulating tumour cells may represent a step towards a better understanding. The clinical details of 269 me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01852321ec88f001ef2054caca76aa89
https://pubmed.ncbi.nlm.nih.gov/16314736
https://pubmed.ncbi.nlm.nih.gov/16314736
Autor:
Kinga, Borbola, Teodóra, Bánfalvi, Zsuzsanna, Fejos, Gabriella, Liszkay, Andrea, Papp, Béla, Horváth, Katalin, Gilde
Publikováno v:
Orvosi hetilap. 146(28)
Malignant melanoma is the most aggressive type of skin cancers, involving the cutis and the mucosa. Its incidence keeps increasing dramatically in the last decades. It appears rarely in childhood. The main environmental risk factors are: excessive su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::89ec76ea3c2bc469795a4de8c1811347
https://pubmed.ncbi.nlm.nih.gov/16130442
https://pubmed.ncbi.nlm.nih.gov/16130442
Publikováno v:
Histopathology. 44(2)
Aims : To compare the routinely used polyclonal anti-S100 and a mouse monoclonal anti-S100B antibody for their accuracy in the detection of the S100B expression profile (pattern and intensity) in a series of 67 primary (n = 37) and lymph node metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fb27ccce499011d3f0b9ea25b058886
https://pubmed.ncbi.nlm.nih.gov/14764062
https://pubmed.ncbi.nlm.nih.gov/14764062
Publikováno v:
Magyar onkologia. 48(1)
The S100 protein family constitutes the largest subgroup of the Ca binding proteins. To date 20 members of the family were discovered. S100 proteins regulate intracellular processes such as cell growth and motility, cell cycle regulation, transcripti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a3223201132e21e502b249bf1b53068d
https://pubmed.ncbi.nlm.nih.gov/15105899
https://pubmed.ncbi.nlm.nih.gov/15105899
Autor:
Teodóra, Bánfalvi, Mariann B, Edesné, Mária, Gergye, Nóra, Udvarhelyi, Zsolt, Orosz, Katalin, Gilde, Tibor, Kremmer, Szabolcs, Ottó, József, Tímár
Publikováno v:
Magyar onkologia. 47(1)
Extracellular tumour markers may have potential role in the follow-up of patients with malignant melanoma, in therapy monitoring and in prediction of prognosis. In our article circulating tumour markers in melanoma (melanoma inhibitory activity, lipi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::85feed468ed7dcd3abb0bd2965cd603e
https://pubmed.ncbi.nlm.nih.gov/12704461
https://pubmed.ncbi.nlm.nih.gov/12704461
Autor:
Gabriella, Liszkay, Gábor, Péley, István, Sinkovics, Ilona, Péter, Zsuzsanna, Fejôs, Béla, Horváth, Teodóra, Bánfalvi, Katalin, Gilde, István, Köves
Publikováno v:
Magyar onkologia. 47(1)
Report on clinical observations obtained with sentinel lymph node surgery for malignant melanoma and during follow-up at the Department of Dermatology, National Institute of Oncology, Budapest.In the period from November, 1997 to September, 2002, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::09cb3a74c2df25a75c83ce7f97ad7dae
https://pubmed.ncbi.nlm.nih.gov/12704459
https://pubmed.ncbi.nlm.nih.gov/12704459
Publikováno v:
European journal of cancer (Oxford, England : 1990). 39(2)
5-S-Cysteinyldopa (5-S-CD) is a precursor of pheomelanin. S-100B protein is a low molecular weight, acidic, calcium binding, cytoplasmic protein. In this study, the concentration changes of serum 5-S-CD and S-100B protein in melanomas of all stages w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e068d2df51509dd9647c954f350b7b14
https://pubmed.ncbi.nlm.nih.gov/12509947
https://pubmed.ncbi.nlm.nih.gov/12509947